- Home
- INMB vs ACR Comparison
INMB vs ACR Comparison
Compare INMB & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INMB | ACR |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.1M | 169.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | INMB | ACR |
|---|---|---|
| Price | $1.56 | $20.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.30 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 472.5K | 46.8K |
| Earning Date | 10-30-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.65 |
| EPS | N/A | ★ 0.95 |
| Revenue | $50,000.00 | ★ $88,952,000.00 |
| Revenue This Year | $264.29 | $4.05 |
| Revenue Next Year | $14,337.26 | $0.38 |
| P/E Ratio | ★ N/A | $21.38 |
| Revenue Growth | ★ 19.05 | 14.87 |
| 52 Week Low | $1.38 | $15.64 |
| 52 Week High | $11.64 | $24.61 |
Technical Indicators
Market Signals| Indicator | INMB | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 39.84 | 29.11 |
| Support Level | $1.75 | $23.48 |
| Resistance Level | $1.63 | $21.89 |
| Average True Range (ATR) | 0.11 | 0.74 |
| MACD | -0.04 | -0.40 |
| Stochastic Oscillator | 17.71 | 3.07 |
Price Performance
Historical ComparisonAbout INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.